Trial record 1 of 1 for:    NCT01711593
Previous Study | Return to List | Next Study

Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma (MGH-002)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Massachusetts General Hospital
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Andrew D. Luster, M.D.,Ph.D., Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01711593
First received: June 28, 2012
Last updated: December 18, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2021
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)